-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Market Perform on Hims & Hers Health, Lowers Price Target to $17.5

Benzinga·02/24/2026 20:22:45
Listen to the news
Leerink Partners analyst Michael Cherny maintains Hims & Hers Health (NYSE:HIMS) with a Market Perform and lowers the price target from $20 to $17.5.